Visiongain has published a new report on Periodontal Therapeutics Market Report 2021-2031: Forecasts By Product (Systemic Antibiotics, and Local Antibiotics), By Type (Gingivitis, Chronic Periodontitis, Aggressive Periodontitis, And Necrotizing Periodontal disease), By Drug Type (Generic, and Branded), By Patient Demographics (Adults, Geriatric, Pediatric, By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/periodontal-therapeutics-market-2021/#download_sampe_div
COVID-19 Impact on Periodontal Therapeutics Market
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Periodontal Therapeutics market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analyzed herein the report are mentioned below:
Market Drivers
Increasing Prevalence of Periodontal Diseases around the World
The burden of periodontal diseases is increasing very rapidly around the world, and it is expected to continuously rising over the forecast period. Periodontal disease is related to the tissues which hold teeth in place. The disease mostly occurs due to oral unhygienic, smoking, diabetes, hormonal changes in girls and women among others. The increasing prevalence is periodontal disease is creating a huge demand for the periodontal therapeutics. Due to which increasing prevalence of periodontal disease around the world is working as a driver for the periodontal therapeutics market.
Market Opportunities
Increasing therapeutic Advancements in Periodontal Therapeutics
The burden of periodontal diseases has guided various leading market players to increase their research and development for periodontal therapeutics. Research and development for new advanced periodontal therapeutics are expected to increase adoption of periodontal therapeutics for the treatment of periodontal disease. Currently, various manufacturers are in the development phase and some have already launched clinical trials for periodontal therapeutics which is expected to fulfil demand and create new opportunities for periodontal therapeutics market.
Growing awareness regarding Periodontal Disease
Governments, international organizations and regulatory authorities in various developing nations are making huge efforts for increasing awareness for diagnosis and treatment of periodontal diseases. Increasing focus on raising awareness for diagnosis and treatment of periodontal diseases is expected to untapped the potential markets in the emerging nations by increasing the diagnosis and treatment rate and increasing public spending towards it. Due to this reason the factor is expected to create various opportunities for the periodontal therapeutics market.
Get Detailed TOC @ https://www.visiongain.com/report/periodontal-therapeutics-market-2021/#download_sampe_div
Competitive Landscape
Top companies (Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma
3M Company) constitute more than XX% share of the global Periodontal Therapeutics market. Other companies profiled in the report include: Oral Science, Kaken Pharmaceutical Co., Ltd., Galderma S.A., OASIS Medical, AFT Pharmaceuticals, I-Med Pharma Inc., Dentsply Sirona, Biohorizons, Zimmer Biomet, Emergent Biosolutions, Inc., and F. Hoffmann-La Roche Ltd. others Some of the key developments are listed below:
● In 2017, Geistlich Pharma started clinical trials for PerioSept, which is a new experimental gel formulation. PerioSept is developed to be used as an adjunctive therapy for periodontitis treatment. Once the therapy is approved by the authority it will help the company widen revenue generation from a market focused product portfolio.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the periodontal therapeutics market and leading companies. You will find data, trends and predictions.
Find more Visiongain research reports on Therapeutic Drug Sector click on the following links:
- Meningococcal Vaccines Market
- Global Contract Research Organisations (CROs) Market
- Biopharmaceuticals Contract Manufacturing Market
- Global Biosimilars and Follow-On Biologics Market
- Global Biosimilar Monoclonal Antibodies Market
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com
About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.
Contact:
Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Web: https://www.visiongain.com
Follow Us: LinkedIn | Twitter
-
SOURCE Visiongain Limited.
